Cataract Surgery Outcomes in Patients with Chronic or Recurrent Uveitis

Abstract

A AB BS S T TR RA AC CT T O Ob bj je ec ct ti iv ve e: : To investigate the outcomes of phacoemulsification and posterior intraocular lens implantation (IOL) in patients with chronic or recurrent uveitis. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : The records of 84 patients, who had phacoemulsification and IOL implantation between 2010 and 2015, were retrospectively examined. The main outcomes were final visual acuity, postoperative complications, the presence of relapse, the clinical features of patients who suffered a recurrence of intraocular inflammation and the effect of triamcinolone acetonide injection into the anterior chamber during surgery on the recurrence of inflammation after cataract surgery within the first 6 months. R Re es su ul lt ts s: : The study included 109 eyes of 84 patients. The mean follow-up time was 52.6±41.8 (9-224) months. During the follow-up, posterior capsule opacification occurred in 48 (44.0%), deposits on the IOL surface in 19 (17.4%), posterior synechiae in 2 (1.8%), epiretinal membrane in 4 (3.6%), glaucoma in 7 (6.4%), and macular edema in 5 (4.5%) patients. The best corrected visual acuity with the Snellen chart at the final visit was ≤0.16 in 66.7% of serpiginous choroidopathy patients and 38% of Behçet patients. These rates were higher than with other clinical etiologies. Recurrence of uveitis within 6 months after cataract surgery occurred in 15 (13.7%) eyes. Recurrence was most common in patients with Behcet's disease. Pre-existing macular lesions were accompanied by poor visual outcomes. There was no difference between the eyes administered triamcinolone into the anterior chamber or not, regarding the frequency of attacks within the first 6 months or the postoperative complications. C Co on nc cl lu us si io on n: : Cataract surgery outcomes in patients with uveitis are satisfactory. However, patients with Behcet's disease have higher risk for relapse of intraocular inflammation and worse visual outcomes. K Ke ey yw wo or rd ds s: : Cataract; triamcinolone; uveitis; visual acuity Ö ÖZ ZE ET T A Am ma aç ç: : Kronik veya tekrarlayan üveitik hastalarda fakoemülsifikasyon ve arka kamara göz içi lensi (GİL) yerleştirilen hastaların sonuçlarını değerlendirmek. G Ge er re eç ç v ve e Y Yö ön nt te em ml le er r: : 2010 ila 2015 yılları arasında fakoemülsifikasyon ve arka kamara GİL'i yerleştirilen 84 hastanın kayıtları geriye dönük olarak incelendi. Sonuçların değerlendirilmesinde, sonuç görme keskinliği, cerrahi sonrası komplikasyonlar, atak varlığı, cerrahiyi takiben ilk 6 ay içerisinde atak geçiren hastaların özellik-leri ve cerrahi esnasında ön kamaraya triamsinolon verilen hastalarda inflamasyon aktivitesi üze-rine olan etkisi değerlendirildi. B Bu ul lg gu ul la ar r: : Çalışma, 84 hastanın 109 gözünü kapsamaktaydı. Ortalama takip süresi 52,6±41,8 (9-224) ay idi. Takip süresi boyunca, arka kapsül kesafeti 48 (%44,0), GİL'nin ön yüzeyinde birikim 19 (%17,4), arka sineşiler 2 (%1,8), epiretinal membran 4 (%3,6), glokom 7 (%6,4) ve maküler ödem 5 (%4,5) ...